RonaldJohnGebhartMD

Associate Professor, Internal Medicine, University of Utah School of Medicine

Dr. Gebhart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
500 Foothill Dr
Chief Of Staff (11)
Salt Lake City, UT 84148
Phone+1 435-659-1496

Fax+1 435-658-2669

Dr. Ronald Gebhart is an infectious disease specialist based in Salt Lake City, UT. He completed his internal medicine residency at San Antonio Uniformed Services Health Education Consortium and an infectious disease fellowship at Virginia Commonwealth University Health System. Dr. Gebhart graduated from Virginia Commonwealth University School of Medicine in 1972. He has published extensively in his field, with notable works on Timentin, SF 86-327, Primaxin, itraconazole, and oxiconazole, receiving numerous citations in scientific publications.

Virginia Commonwealth University Health SystemFellowship, Infectious Disease, 1981 - 1984
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1972 - 1975
Virginia Commonwealth University School of MedicineClass of 1972

PubMed

13 citations
Timentin in the treatment of symptomatic complicated urinary tract infections in adult patients.
Ronald J. Gebhart, Richard J. Duma, Patricia M. Patterson
The American Journal of Medicine. 1985-11-29
74 citations
In-vitro studies with SF 86-327, a new orally active allylamine derivative.
Smith Shadomy, Ana Espinel-Ingroff, Ronald J. Gebhart
Sabouraudia. 1985-03-01
7 citations
Primaxin in the treatment of acute bacterial pneumonia in adults
Ronald J. Gebhart, Richard J. Duma, Patricia M. Patterson, Jane W. Bagett, Denise S. Williams
The Journal of Antimicrobial Chemotherapy. 1985-02-01